Fresenius Medical Care AG (FMS)
21.48
+0.93
(+4.53%)
USD |
NYSE |
Apr 23, 16:00
21.46
-0.02
(-0.12%)
Pre-Market: 20:00
Fresenius Medical Care Price to Book Value: 0.8372 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.8372 |
| April 22, 2024 | 0.801 |
| April 19, 2024 | 0.7616 |
| April 18, 2024 | 0.7558 |
| April 17, 2024 | 0.7394 |
| April 16, 2024 | 0.725 |
| April 15, 2024 | 0.7316 |
| April 12, 2024 | 0.7168 |
| April 11, 2024 | 0.7378 |
| April 10, 2024 | 0.7437 |
| April 09, 2024 | 0.7499 |
| April 08, 2024 | 0.7367 |
| April 05, 2024 | 0.7308 |
| April 04, 2024 | 0.73 |
| April 03, 2024 | 0.7339 |
| April 02, 2024 | 0.7316 |
| April 01, 2024 | 0.7441 |
| March 28, 2024 | 0.7515 |
| March 27, 2024 | 0.7546 |
| March 26, 2024 | 0.737 |
| March 25, 2024 | 0.7374 |
| March 22, 2024 | 0.7304 |
| March 21, 2024 | 0.7429 |
| March 20, 2024 | 0.7663 |
| March 19, 2024 | 0.7612 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.7417 |
| March 15, 2024 | 0.7421 |
| March 14, 2024 | 0.7651 |
| March 13, 2024 | 0.7827 |
| March 12, 2024 | 0.7846 |
| March 11, 2024 | 0.7823 |
| March 08, 2024 | 0.7932 |
| March 07, 2024 | 0.8049 |
| March 06, 2024 | 0.7815 |
| March 05, 2024 | 0.8092 |
| March 04, 2024 | 0.7277 |
| March 01, 2024 | 0.7546 |
| February 29, 2024 | 0.7487 |
| February 28, 2024 | 0.7526 |
| February 27, 2024 | 0.7647 |
| February 26, 2024 | 0.7675 |
| February 23, 2024 | 0.755 |
| February 22, 2024 | 0.7624 |
| February 21, 2024 | 0.753 |
| February 20, 2024 | 0.8037 |
| February 16, 2024 | 0.8228 |
| February 15, 2024 | 0.8201 |
| February 14, 2024 | 0.8263 |
| February 13, 2024 | 0.7846 |
| February 12, 2024 | 0.7795 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5081
Minimum
Oct 10 2022
2.080
Maximum
Jul 29 2020
1.310
Average
1.423
Median
Oct 27 2021
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | 0.5946 |
| NuCana PLC | 0.446 |
| Biophytis SA | -- |
| TC BioPharm (Holdings) PLC | 1.476 |
| DaVita Inc | 11.07 |
Price to Book Value Related Metrics
| PE Ratio | 23.35 |
| PS Ratio | 0.5985 |
| Price to Free Cash Flow | 5.989 |
| Price | 21.48 |
| Earnings Yield | 4.28% |
| Market Cap | 12.61B |
| Operating PE Ratio | 7.592 |
| Normalized PE Ratio | 21.56 |